Boston Scientific Corporation (BSX) fundamentals score
Boston Scientific operates pursuant to five strategic imperatives. It aims to: Strengthen Category Leadership, Expand into High Growth Adjacencies, Drive Global Expansion, Fund the Journey to Fuel Growth and Develop Key Capabilities. It believes that its
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NYSE
Overall: 7.8 out of 10, Good long-term fundamentals
- Growth: 6.4/10
- Profitability: 7.5/10
- Financial health: 7.6/10
- Earnings quality: 9.0/10
- Valuation: 9.4/10
Scores are calculated from Boston Scientific Corporation’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10